Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic

Status Recruiting

Clinical Trial Summary

Systemic rheumatological diseases often occur in young women of childbearing age and can therefore impact fertility. There are diseases, such as arthritis, which present no contraindication to assisted reproductive techniques (ARTs), because there is no influence on the disease itself if the disease activity at conception is stable. On the other hand, patients suffering from connective tissue diseases, primarily Systemic Lupus Erythematosus (SLE) and patients suffering from primary or SLE-related Anti-Phospholipid Antibody Syndrome (APS), deserve more targeted therapies both in the context of ARTs and in the ensuing pregnancy. To evaluate the response to ARTs in patients with systemic rheumatological diseases, both in terms of reactivation of the underlying pathology and in terms of ARTs outcome.

Clinical Trial Description

According to standard clinical practice related to medically assisted procreation treatments, for controlled ovarian stimulation aimed at oocyte recovery, patients underwent therapy with recombinant, biosimilar, or purified human gonadotropins and eventual suppression of spontaneous ovulation with gonadotropin-releasing hormone stimulating antagonist (gnRH-antagonist), and this information will therefore be recorded. The subsequent final induction of oocyte maturity can be by purified human chorionic gonadotropin (hCG), by gonadotropin-releasing hormone stimulating hormone analog (GnRHa), or by the combination of the two, and this information will therefore also be recorded. Similarly, therapies routinely administered for endometrial preparation and luteal support during embryo transfer procedures will also be recorded (transdermal estradiol, oral estradiol; transvaginal micronized progesterone; subcutaneous progesterone). With regard to the types of PMA used, patients may have undergone homologous or heterologous procedures based on the patient's own choice and specialist indications. The IVF technique is an in vitro fertilization that consists of the union of the egg with the sperm in the laboratory -in vitro- for the purpose of obtaining already fertilized embryos to be transferred into the maternal uterus. The ICSI technique consists of intracytoplasmic sperm injection and involves the insemination of an oocyte by micro-injection of a single sperm directly into it. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05807256
Study type	Observational
Source	IRCCS San Raffaele
Contact	Patrizia Rovere Querini, PhD, MD
Phone	+390226436095
Email	rovere.patrizia@hsr.it
Status	Recruiting
Phase
Start date	May 4, 2022
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03249896` - Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes	N/A
Completed	`NCT06338254` - Efficacy of Percussion Massage Therapy Applied to the Lower Extremity on Pain, Edema in Pregnant Women	N/A
Recruiting	`NCT04825093` - Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19	N/A
Completed	`NCT04739462` - SMS Maama Project COVID-19	N/A
Recruiting	`NCT04519593` - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma	N/A
Recruiting	`NCT03313024` - Berlin-Brandenburg Pregnancy Cohort
Completed	`NCT02577536` - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting	`NCT06430853` - Psychobiological Interventions in Pregnancy	N/A
Not yet recruiting	`NCT06357962` - Semi-permanent Acupuncture Effect on Cervical Ripening	N/A
Not yet recruiting	`NCT03661749` - Urinary Protein to Creatinine Ratio in Term Pregnant Women	N/A
Completed	`NCT02970721` - Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
Completed	`NCT02191774` - Medical Abortion up to 10 Weeks Gestation at Home
Completed	`NCT01322529` - Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be	N/A
Completed	`NCT00746551` - Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment	Phase 4
Completed	`NCT00678080` - Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes	N/A
Completed	`NCT00634530` - Impact of a Nutritional Intervention Program for Weight Control During Pregnancy	N/A
Completed	`NCT00197561` - Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection	Phase 3
Completed	`NCT05527327` - Pannus Retraction for Ultrasound Evaluation of the Obese Gravida: A Pilot Study	N/A
Recruiting	`NCT05551078` - Thrombophilia Screening After Severe IUGR
Recruiting	`NCT03100084` - PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms